Tuesday, August 23, 2016
Loblaw enters into agreement to purchase Canadian healthcare technology company, QHR. Deal for $3.10 in cash per each QHR share.
Deal for approximately $170 million in aggregate.
QHR shareholders who collectively control approximately 23% of QHR, have committed to vote in favor of transaction.
Source : reuters.com
